CVC Concludes Delisting Offer for CompuGroup Medical

CVC Capital Partners has successfully concluded its public delisting offer for CompuGroup Medical SE & Co. KGaA, securing a 27.78% stake in the company. The founding family Gotthardt retains majority control with a 50.12% stake. The delisting from the Frankfurt Stock Exchange became effective on June 24, 2025.

Post-delisting, CVC joins the company's Administrative Board, expanding it to six members. The Gotthardt family remains in control with representation by three members. CVC aims to collaborate with CompuGroup Medical on long-term growth and innovation strategies. A public delisting offer price was set at EUR 22.00 per share, with the final settlement due by July 9, 2025.